Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print February 25, 2004.
Biol Reprod 2004, 10.1095/biolreprod.103.023390
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
71/1/366    most recent
biolreprod.103.023390v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borman, S. M.
Right arrow Articles by Zelinski-Wooten, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borman, S. M.
Right arrow Articles by Zelinski-Wooten, M. B.
Agricola
Right arrow Articles by Borman, S. M.
Right arrow Articles by Zelinski-Wooten, M. B.
Submitted September 17, 2003
Returned for revision October 16, 2003
Accepted February 24, 2004

Female Reproductive Tract


Progesterone Promotes Oocyte Maturation, but Not Ovulation, in Nonhuman Primate Follicles Without a Gonadotropin Surge

Sherri M. Borman , Charles L. Chaffin , Kristine M. Schwinof , Richard L. Stouffer , and Mary B. Zelinski-Wooten *

* To whom correspondence should be addressed. E-mail: zelinski{at}ohsu.edu.

Abstract
During the peri-ovulatory interval, intrafollicular progesterone (P) prevents follicular atresia and promotes ovulation. Whether P influences oocyte quality or maturation and follicle rupture independent of the midcycle gonadotropin surge was examined. Rhesus monkeys underwent controlled ovarian stimulation with recombinant human gonadotropins followed by (a) Experiment 1: an ovulatory bolus of hCG alone or with a steroid synthesis inhibitor (trilostane, TRL), or TRL + the progestin R5020; or (b) no hCG but rather, sesame oil (vehicle), R5020 or dihydrotestosterone (DHT). In Experiment 1, the majority of oocytes remained immature (65 ± 20%) by 12 h post-hCG. However, the percentage of degenerating oocytes increased (p<0.05) with TRL (42 ± 22% vs. 0% controls), but was reduced (p<0.05) by progestin replacement (15 ± 7%). By 36 h post-hCG, the majority of oocytes in all three groups reached metaphase II (MI). In Experiment 2, no evidence of follicle rupture was observed in the vehicle, R5020 or DHT groups. Despite the absence of hCG, a significant (p<0.05) percentage of oocytes resumed meiosis to metaphase I in R5020- (41 ± 9) and DHT- (36 ± 15), but not vehicle- (4 ± 4), treated animals. Only oocytes from R5020-treated animals continued meiosis in vivo to MII. More (p<0.05) oocytes fertilized in vitro with R5020 (40%) than with vehicle (20%) or DHT (22%). Thus, P is unable to elicit ovulation in the absence of an ovulatory gonadotropin surge; however P and/or androgens may prevent oocyte atresia and promote oocyte nuclear maturation in primate follicles.

Key words: In vitro fertilization • Meiosis • Ovulation • Ovum • Progesterone





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the Society for the Study of Reproduction.